News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,049 Results
Type
Article (1356)
Company Profile (18)
Press Release (60675)
Section
Business (28206)
Career Advice (40)
Deals (4412)
Drug Delivery (2)
Drug Development (6509)
Employer Resources (3)
FDA (1063)
Job Trends (1529)
News (38312)
Policy (1898)
Tag
Academia (135)
Accelerated approval (1)
Allergies (14)
Alliances (2232)
ALS (9)
Alzheimer's disease (77)
Antibody-drug conjugate (ADC) (57)
Approvals (1142)
Artificial intelligence (23)
Autoimmune disease (12)
Automation (2)
Bankruptcy (11)
Best Places to Work (1511)
Biosimilars (14)
Biotechnology (10)
Bladder cancer (41)
Brain cancer (8)
Breast cancer (84)
Cancer (634)
Cardiovascular disease (46)
Career advice (39)
CAR-T (18)
Cell therapy (64)
Cervical cancer (8)
Clinical research (6172)
Collaboration (78)
Compensation (117)
Complete response letters (4)
COVID-19 (170)
CRISPR (8)
C-suite (34)
Cystic fibrosis (7)
Data (811)
Depression (19)
Diabetes (31)
Diagnostics (616)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (11)
Drug pricing (6)
Duchenne muscular dystrophy (6)
Earnings (26674)
Editorial (3)
Employer branding (1)
Employer resources (3)
Events (6898)
Executive appointments (37)
FDA (1551)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (92)
Gene editing (12)
Generative AI (1)
Gene therapy (28)
GLP-1 (70)
Government (212)
Guidances (248)
Healthcare (1941)
HIV (6)
IgA nephropathy (11)
Immunology and inflammation (19)
Immuno-oncology (3)
Indications (12)
Infectious disease (194)
Inflammatory bowel disease (18)
Influenza (11)
Intellectual property (28)
Interviews (3)
IPO (3548)
IRA (1)
Job creations (110)
Job search strategy (33)
JPM (5)
Kidney cancer (2)
Labor market (2)
Layoffs (12)
Leadership (2)
Legal (292)
Liver cancer (11)
Longevity (1)
Lung cancer (86)
Lymphoma (68)
Machine learning (1)
Management (1)
Manufacturing (38)
MASH (24)
Medical device (1623)
Medtech (1629)
Mergers & acquisitions (985)
Metabolic disorders (89)
mRNA (3)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (11)
Neuropsychiatric disorders (8)
Neuroscience (169)
NextGen: Class of 2026 (430)
Non-profit (231)
Obesity (34)
Opinion (2)
Ovarian cancer (27)
Pain (19)
Pancreatic cancer (47)
Parkinson's disease (18)
Partnered (5)
Patents (51)
Patient recruitment (32)
Peanut (7)
People (1853)
Pharmaceutical (4)
Pharmacy benefit managers (4)
Phase 1 (1537)
Phase 2 (2531)
Phase 3 (2535)
Pipeline (1357)
Policy (5)
Postmarket research (233)
Preclinical (480)
Press Release (4)
Prostate cancer (20)
Radiopharmaceuticals (30)
Rare diseases (61)
Real estate (211)
Regulatory (1712)
Reports (5)
Research institute (116)
Resumes & cover letters (2)
Rett syndrome (5)
RNA editing (1)
RSV (7)
Schizophrenia (17)
Series A (9)
Series B (10)
Service/supplier (1)
Sickle cell disease (5)
Spinal muscular atrophy (5)
Startups (142)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
Vaccines (83)
Venture capital (3)
Weight loss (14)
Women's health (12)
Worklife (2)
Date
Today (30)
Last 7 days (103)
Last 30 days (323)
Last 365 days (4090)
2026 (448)
2025 (4159)
2024 (4822)
2023 (5397)
2022 (5847)
2021 (5983)
2020 (5340)
2019 (3856)
2018 (3153)
2017 (2765)
2016 (1890)
2015 (2598)
2014 (1952)
2013 (1281)
2012 (1518)
2011 (1633)
2010 (1432)
Location
Africa (38)
Alabama (6)
Alaska (2)
Arizona (20)
Asia (4256)
Australia (421)
California (1700)
Canada (342)
China (156)
Colorado (72)
Connecticut (46)
Delaware (55)
Europe (7589)
Florida (252)
Georgia (78)
Hawaii (1)
Idaho (1)
Illinois (92)
India (7)
Indiana (106)
Iowa (1)
Japan (49)
Kansas (56)
Kentucky (4)
Louisiana (8)
Maine (11)
Maryland (165)
Massachusetts (1056)
Michigan (35)
Minnesota (83)
Missouri (11)
Montana (3)
Nevada (10)
New Hampshire (9)
New Jersey (556)
New York (334)
North Carolina (167)
Northern California (893)
Ohio (34)
Oklahoma (1)
Pennsylvania (303)
South America (81)
South Carolina (5)
Southern California (625)
Tennessee (20)
Texas (313)
United States (5673)
Utah (51)
Virginia (15)
Washington D.C. (1)
Washington State (97)
Wisconsin (8)
62,049 Results for "82".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mendra Launches with $82 Million Series A to Acquire, Develop, and Commercialize Therapeutics for High Unmet Need Rare Diseases
January 22, 2026
·
2 min read
Press Releases
U.S. Drug Utilization Management Market Size to Exceed USD 82.07 Billion by 2034
November 24, 2025
·
1 min read
Press Releases
Radiation Oncology Market Size to Surpass USD 32.82 Billion by 2034
October 8, 2025
·
1 min read
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
In a Phase 1 study, 82% of patients on VIR-5500 achieved at least a 50% reduction in PSA levels—a result analysts praised as competitive in the prostate cancer space.
February 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Azalea Therapeutics Launches with $82 Million Financing to Redefine Precision Genomic Medicines by Engineering Cells Directly Inside Each Patient
November 5, 2025
·
6 min read
Press Releases
Anti-Obesity Drug Market Outlook 2025–2032: Strong CAGR of 18.01% with USD 82.55 Billion Valuation
October 17, 2025
·
1 min read
Press Releases
McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share
July 31, 2025
·
1 min read
Press Releases
Digital Biomarkers Market Size Worth USD 31.82 Billion by 2034 Fueled by Rising Smartphone and Wearable Adoption at 22.71% CAGR
October 1, 2025
·
1 min read
Press Releases
Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chronic Hepatitis D (CHD)
November 10, 2025
·
6 min read
Press Releases
Clinical Oncology Next Generation Sequencing Market Size to Reach USD 2,129.82 Million By 2034
July 16, 2025
·
1 min read
1 of 6,205
Next
